Milestone Pharmaceuticals Inc (MIST)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
2.0500 +0.1500 (+7.89%) 03/24/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 2.0900 +0.0400 (+1.95%) 19:58 ET
for Mon, Mar 24th, 2025
Results
download Want to compare other data? Select FieldsSymbol | MIST | AZN | AMGN | GILD | VRTX |
Company | Milestone Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
Open | 1.9900 | 73.84 | 315.00 | 107.01 | 505.00 |
High | 2.2000 | 74.42 | 317.58 | 107.39 | 513.97 |
Low | 1.9900 | 73.79 | 313.43 | 106.10 | 501.00 |
Last | 2.0500 | 74.09 | 314.38 | 106.74 | 511.74 |
Change | +0.1500 | -0.84 | -1.66 | -0.34 | +8.54 |
% Change | +7.89% | -1.12% | -0.53% | -0.32% | +1.70% |
Volume | 3,505,500 | 3,741,300 | 2,439,400 | 8,563,300 | 1,237,600 |
20-Day Average Volume | 2,200,000 | 6,207,435 | 3,300,975 | 10,862,030 | 1,374,555 |
Previous Close | 1.9000 | 74.93 | 316.04 | 107.08 | 503.20 |
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 1.9200 | 76.26 | 315.01 | 112.40 | 495.20 |
20-Day Raw Stochastic | 55.05% | 6.57% | 34.41% | 13.37% | 82.80% |
20-Day Relative Strength | 51.59% | 49.33% | 57.43% | 49.52% | 63.39% |
Weighted Alpha | +5.03 | +6.48 | +10.34 | +51.57 | +23.41 |
Today's Opinion | 72% Buy | 16% Buy | 40% Buy | 80% Buy | 72% Buy |
Previous Opinion | 24% Buy | 40% Buy | 56% Buy | 80% Buy | 72% Buy |
Last Month's Opinion | 72% Buy | 8% Buy | 24% Sell | 100% Buy | 24% Buy |
Performance | |||||
5-Days | |||||
%Chg | -14.94% since 03/17/25 | -4.24% since 03/17/25 | -0.88% since 03/17/25 | -4.92% since 03/17/25 | -0.39% since 03/17/25 |
Low | 1.8700 on 03/21/25 | 73.79 on 03/24/25 | 311.16 on 03/21/25 | 104.70 on 03/20/25 | 501.00 on 03/24/25 |
High | 2.4600 on 03/18/25 | 77.52 on 03/18/25 | 319.31 on 03/18/25 | 112.20 on 03/18/25 | 516.50 on 03/18/25 |
1-Month | |||||
%Chg | +8.47% since 02/24/25 | -0.80% since 02/24/25 | +1.50% since 02/24/25 | -3.86% since 02/24/25 | +6.25% since 02/24/25 |
Low | 1.5000 on 02/28/25 | 73.79 on 03/24/25 | 303.10 on 02/27/25 | 104.70 on 03/20/25 | 473.51 on 02/27/25 |
High | 2.5000 on 03/17/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
3-Month | |||||
%Chg | +10.81% since 12/24/24 | +11.75% since 12/24/24 | +18.86% since 12/24/24 | +13.61% since 12/24/24 | +25.37% since 12/24/24 |
Low | 1.5000 on 02/28/25 | 64.22 on 01/14/25 | 257.05 on 01/06/25 | 88.57 on 01/10/25 | 397.24 on 01/13/25 |
High | 2.7500 on 12/31/24 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
6-Month | |||||
%Chg | +33.12% since 09/24/24 | -3.62% since 09/24/24 | -5.00% since 09/24/24 | +27.39% since 09/24/24 | +10.53% since 09/24/24 |
Low | 1.4000 on 11/01/24 | 62.75 on 11/18/24 | 253.30 on 12/19/24 | 81.83 on 09/26/24 | 377.85 on 12/19/24 |
High | 2.7500 on 12/31/24 | 79.76 on 10/02/24 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
Key Statistics | |||||
Market Capitalization, $K | 101,373 | 232,373,984 | 169,778,272 | 133,351,648 | 129,216,736 |
Shares Outstanding, K | 53,354 | 3,101,214 | 537,205 | 1,245,346 | 256,790 |
Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
Annual Net Income | -41,520,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
Last Quarter Sales | 0 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
Last Quarter Net Income | -12,360,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
60-Month Beta | 1.83 | 0.41 | 0.53 | 0.21 | 0.41 |
Per-Share Information | |||||
Most Recent Earnings | -0.19 on 03/13/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
Latest Earnings Date | 05/12/25 | 04/24/25 | 05/01/25 | 04/24/25 | 05/05/25 |
Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
Ratios | |||||
Price/Earnings ttm | 0.00 | 18.62 | 15.90 | 22.97 | 0.00 |